In 2021, the extracorporeal membrane oxygenation machine market was worth around USD 529.4 million, and it is projected to advance at a 5.2% CAGR from 2021 to 2030, hitting USD 834.5 million in 2030, according to P&S Intelligence.

 

This development can be ascribed to the increasing occurrence of respiratory failures and cardiopulmonary illnesses, and the rising number of populaces needing ECMO treatment because of the increasing incidence of chronic obstructive pulmonary illnesses. Further, technological enhancements in the healthcare sector, several government steps to spread awareness regarding such diseases and the qualities of ECMO devices, and huge research and development expenditure boosts the industry.

 

In 2021, the oxygenators category had the largest market share, of above 35%, and is projected to continue to be dominance in the future as well. This is mainly because of the increasing occurrence of severe lung diseases among kids and the mounting knowledge regarding the functions of ECMO devices.

 

Moreover, these oxygenators are extensively utilized by perfusionists in cardiac surgical methods in combination with heart-lung devices and are more widely utilized in neonatal intensive care units related to Echo machines.

 

In 2021, the North American industry held the largest market share, at approximately 40%, and is estimated to be in the leading spot throughout the decade. This can be credited to the existence of a huge patient base going through cardiopulmonary syndromes and lung failure and growth in the acceptance of ECMO machines in the continent.

The APAC extracorporeal membrane oxygenation machine market is set to witness the fastest development, growing at a CAGR of above 5% in the coming years. mainly because of increasing people's knowledge regarding the benefits of ECMO machines and the elderly population.

 

Hence, the increasing occurrence of respiratory failures and cardiopulmonary illnesses, and the rising number of populaces needing ECMO treatment because of the increasing incidence of chronic obstructive pulmonary illnesses, are the major factors propelling the extracorporeal membrane oxygenation machine industry.